Mouth cancer is relatively uncommon compared to cancers of the breast, lung, or colon, but it’s far from rare. In the United States alone, an estimated 60,480 new cases of oral cavity and pharynx cancer will be diagnosed in 2026, with roughly 13,150 deaths. Globally, lip and oral cavity cancers account for nearly 390,000 new cases each year, with rates varying dramatically by region.
How the Numbers Break Down
That 60,480 figure covers cancers of the mouth, tongue, cheeks, gums, floor of the mouth, lips, and the back of the throat (oropharynx). The tongue and floor of the mouth are among the most frequently affected sites inside the mouth itself. Men are diagnosed at roughly twice the rate of women, a gap partly explained by higher rates of tobacco use, alcohol consumption, and HPV infection in men.
Globally, the picture shifts considerably depending on where you live. Asia accounts for about 66% of all lip and oral cavity cancers worldwide, largely driven by high rates in South Central Asia, where chewing tobacco and betel nut use are common. Melanesia and South Central Asia have the highest age-adjusted incidence rates of any region. Papua New Guinea tops the list at 17.5 cases per 100,000 people, compared to far lower rates in North America and Europe.
Who Is Most at Risk
Tobacco use is the single biggest risk factor for cancers inside the mouth. This includes cigarettes, cigars, pipes, and smokeless tobacco. Alcohol is an independent risk factor on its own, but the combination of heavy smoking and heavy drinking is far more dangerous than either habit alone. A large pooled analysis published in Cancer Epidemiology, Biomarkers & Prevention found that people who smoked more than 20 cigarettes a day and drank three or more alcoholic beverages daily had roughly 14 times the risk of head and neck cancer compared to people who did neither.
HPV, specifically HPV type 16, has become a major driver of cancers in the oropharynx (the base of the tongue and tonsils). About 70% of oropharyngeal cancers are linked to HPV, translating to roughly 16,000 cases per year in the U.S. This type of cancer has risen sharply over the past two decades even as smoking-related oral cancers have declined. HPV-related oropharyngeal cancers tend to affect younger adults and generally carry a better prognosis than cancers caused by tobacco.
Survival Rates by Location and Stage
Survival depends heavily on where in the mouth the cancer develops and how early it’s caught. Five-year survival rates, based on data from 2015 to 2021, tell a clear story about the value of early detection:
- Lip cancer: 95% survival when localized, dropping to 46% if it has spread to distant sites.
- Tongue cancer: 88% when localized, 39% when distant.
- Floor of the mouth: 72% when localized, 22% when distant.
- Oropharyngeal cancer: 86% when localized, 40% when distant.
The gap between localized and distant survival is striking, particularly for cancers of the floor of the mouth, where catching it early nearly triples the five-year survival rate. Oropharyngeal cancers have an unusually high regional survival rate (79%), likely because many of these are HPV-positive tumors that respond well to treatment, though current statistics don’t separate HPV-positive from HPV-negative cases.
What Early Signs Look Like
Mouth cancer often starts as something easy to dismiss. A sore on your lip or inside your cheek that won’t heal is the most common early sign. Other things to watch for include a white or reddish patch on the inner lining of your mouth, a lump or thickened area, unexplained loose teeth, persistent mouth or ear pain, and difficulty swallowing or opening your mouth wide. Any of these lasting more than two weeks warrants a visit to your doctor or dentist.
The challenge is that many of these symptoms overlap with harmless conditions like canker sores or irritation from dental work. The two-week rule is a practical threshold: most benign sores heal within that window. One that doesn’t is worth investigating.
How Screening Works
Unlike some cancers that require special imaging or blood tests, mouth cancer screening happens during a routine dental visit. The American Dental Association recommends that dentists perform a visual and tactile examination of the mouth, including the tongue, cheeks, gums, roof of the mouth, and throat, as part of every comprehensive oral health screening. This means your dentist is already looking for signs of cancer each time you sit in the chair, even if they don’t explicitly say so.
If your dentist spots a suspicious lesion, the next step is either an immediate biopsy or a referral to a specialist. For borderline findings, a short watchful waiting period of 10 to 14 days may be appropriate, but anything that persists beyond that window should be biopsied. Regular dental visits, at least once a year, give your dentist repeated opportunities to catch changes early, when survival rates are highest.